IGC Pharma (IGC) Total Debt (2010 - 2026)
IGC Pharma (IGC) reported Total Debt of $218000.0 for Q1 2026, up 62.69% year-over-year from $134000.0 in Q1 2025, and down 55.6% quarter-over-quarter from $491000.0 in Q4 2025.
IGC Pharma (IGC) Total Debt (2010 - 2026) Analysis & Trends
IGC Pharma (IGC) has 17 years of Total Debt data on file, last reported at $218000.0 in Q1 2026.
- Total Debt for Q1 2026 came in at $218000.0, up 62.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $218000.0 (up 62.69% YoY), and the FY2026 annual result was $218000.0, up 62.69% from the prior year.
- Total Debt retreated to $218000.0 in Q1 2026 per IGC's latest filing, from $491000.0 in the prior quarter.
- Over five years, Total Debt peaked at $491000.0 in Q4 2025 and troughed at $132000.0 in Q3 2025.
- A 5-year average of $163764.7 and a median of $139000.0 in 2023 frame the typical range for Total Debt.
- The sharpest annual moves came in 2022 and 2025: Total Debt tumbled 74.66% in 2022, then jumped 266.42% in 2025.
- A 5-year view of Total Debt shows it stood at $141000.0 in 2022, then declined by 2.13% to $138000.0 in 2023, then slipped by 2.9% to $134000.0 in 2024, then jumped by 266.42% to $491000.0 in 2025, then slumped by 55.6% to $218000.0 in 2026.
- Business Quant data shows IGC's Total Debt at $218000.0 in Q1 2026, $491000.0 in Q4 2025, and $132000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | 218,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 218,000.00 |
| Dec 31, 2025 | 491,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 134,000.00 |
| Sep 30, 2024 | 135,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 137,000.00 |
| Dec 31, 2023 | 138,000.00 |
| Sep 30, 2023 | 139,000.00 |
| Jun 30, 2023 | 140,000.00 |
| Mar 31, 2023 | 141,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 146,000.00 |
| Mar 31, 2022 | 147,000.00 |
| Dec 31, 2021 | 148,000.00 |
| Sep 30, 2021 | 149,000.00 |
| Jun 30, 2021 | 150,000.00 |